Tecovirimat for the Treatment of Mpox

Key Points

• This research aims to evaluate the efficacy of tecovirimat in treating adults with mpox.
• Conducted a clinical trial to assess tecovirimat therapy.
• Included adults diagnosed with clade II mpox.
• Measured outcomes such as time to clinical resolution, pain levels, and viral clearance.
• No evidence that tecovirimat therapy shortened time to clinical resolution.
• Treatment did not significantly reduce pain.
• No increase in viral clearance observed among participants.